Could common immune drugs be a secret weapon against Parkinson's?
NCT ID NCT06834191
Summary
This study aims to learn if long-term immunosuppressive drug treatment for other chronic illnesses can slow down the progression of Parkinson's disease. Researchers will compare 80 people with Parkinson's—some taking these immune-suppressing drugs and some not—by measuring their symptom progression and levels of inflammation in the blood. The goal is to understand if reducing inflammation in the body affects how Parkinson's develops over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Neurology, Faculty of Health Science, Medical University of Warsaw
RECRUITINGWarsaw, 02-091, Poland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.